demi lovato glp-1 Weight Loss: Clarifying Rumors and Official Health Updates Demi Lovato revealed she's taking

A systematic review found that combining GLP-1 receptor agonist therapy with structured exercise programs led to greater weight loss compared to medication alone

Clinical manifestations are multifaceted and include disabilities with motor, urinary, intestinal, sexual and mental presentations

The eligibility criteria for most FDA-approved weight loss drugs are as follows: Body mass index (BMI) of 30 or higher (classified as obesity) Body mass index (BMI) of 27 or higher (classified as overweight) with one weight-related health condition, such as hypertension, hyperlipidemia, heart disease, and high blood cholesterol levels

J Nutr (1983) 113:161325

doi: 10.1038/srep16423 30 EbrahimiM.MousaviS